What is Vor Biopharma Inc. Common Stock's Market Cap?

Vor Biopharma Inc. Common Stock's Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Enterprise Value?

Vor Biopharma Inc. Common Stock's Enterprise Value is $614.2M, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Trailing P/E?

Vor Biopharma Inc. Common Stock's Trailing P/E is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's EV / EBITDA?

Vor Biopharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Net Income (TTM)?

Vor Biopharma Inc. Common Stock's Net Income (TTM) is $627.8M, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's EBITDA?

Vor Biopharma Inc. Common Stock's EBITDA is -$147.0M, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Diluted EPS (TTM)?

Vor Biopharma Inc. Common Stock's Diluted EPS (TTM) is 10.61, based on as-reported figures from SEC (XBRL) filings.

What is Vor Biopharma Inc. Common Stock's Net Debt?

Vor Biopharma Inc. Common Stock's Net Debt is -$466.1M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Vor Biopharma Inc. Common Stock

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00NBJRDV3

18.26▼ 0.68 (-3.59%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 18.94
Day's Range: 17.95 – 18.81
52-Week Range: 6.50 – 28.66
Volume: 718.9K
Avg Volume: 1.2M

Share Statistics

Shares Outstanding
Employees: 168
Exchange: XNAS
Listed: 2021-02-05

Share count as of August 6, 2026

Vor Biopharma Inc. Common Stock (VOR) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Vor Biopharma Inc. Common Stock (VOR)

What is Vor Biopharma Inc. Common Stock's Market Cap?: Vor Biopharma Inc. Common Stock's Market Cap is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Enterprise Value?: Vor Biopharma Inc. Common Stock's Enterprise Value is $614.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Trailing P/E?: Vor Biopharma Inc. Common Stock's Trailing P/E is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's EV / EBITDA?: Vor Biopharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Net Income (TTM)?: Vor Biopharma Inc. Common Stock's Net Income (TTM) is $627.8M, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's EBITDA?: Vor Biopharma Inc. Common Stock's EBITDA is -$147.0M, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Diluted EPS (TTM)?: Vor Biopharma Inc. Common Stock's Diluted EPS (TTM) is 10.61, based on as-reported figures from SEC (XBRL) filings.
What is Vor Biopharma Inc. Common Stock's Net Debt?: Vor Biopharma Inc. Common Stock's Net Debt is -$466.1M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · VORAs-filed SEC (XBRL) data